Ascend Wellness (AAWH) reported Q2 2026 net revenue of $126.1M, up 7.9% sequentially, driven by new dispensary openings and higher retail sales. The company said these gains offset pricing pressure and tougher competitive conditions in several markets. Overall, the quarter reflects modest momentum but with ongoing margin/price challenges.
Ascend Wellness (AAWH) reported Q2 2026 net revenue of $126.1M, up 7.9% sequentially, driven by new dispensary openings and higher retail sales. The company said these gains offset pricing pressure and tougher competitive conditions in several markets. Overall, the quarter reflects modest momentum but with ongoing margin/price challenges.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
